+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2020 Global Infectious Disease Molecular Diagnostics Market for 100 Tests: US, Europe, Japan--Supplier Shares by Test, Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review

  • ID: 5022173
  • Report
  • April 2020
  • Region: Global, United States, Europe
  • 1265 pages
  • VPG Market Research
1 of 2

FEATURED COMPANIES

  • Abbott
  • Becton Dickinson
  • Decode Genetics
  • Fujirebio
  • Li-Cor Biosciences
  • Scienion
  • MORE
This new seven-country study contains 1,265 pages, 191 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years.

Report Highlights
  • Business and technological trends in major markets
  • Five-year test volume and sales forecasts
  • Market shares of leading competitors
  • Feature comparison of major analyzers
  • Strategic profiles of leading market players and start-up firms developing innovative products
  • Specific product and business opportunities for instrument and consumable suppliers.
Rationale

The infectious disease molecular diagnostics market is one of the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the infectious disease molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

Geographic Coverage
  • France
  • Germany
  • Italy
  • Japan
  • Spain
  • UK
  • USA
Worldwide Market Overview
  • Laboratories performing DNA sequencing and molecular diagnostic testingfor infectious diseases by country and market segment.
  • Five-year test volume and sales projections by country.
Market Segmentation Analysis
  • Sales and market shares of leading suppliers of infectious disease molecular diagnosticreagent kits and components.
  • Five-year test volume and sales projections for over 40 infectious disease molecular diagnostic assays.
  • A comprehensive analysis of the sequencing market by country and laboratory segment.
  • Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers by country.
Product/Technology Review
  • Comparison of leading infectious disease molecular diagnostic analyzers.
  • Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods.
  • Worldwide listings of companies, universities and research centers developing new molecular Diagnostictechnologies and products.
Competitive Assessments
  • Extensive strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.
  • Abbott
  • Affymetrix
  • Agilent Technologies
  • Applied Gene Technologies
  • Arca Biopharma
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biokit
  • bioMerieux
  • Bio-Rad
  • Biotest
  • Cepheid
  • Decode Genetics
  • Diadexus
  • Eiken Chemical
  • Elitech Group
  • Enzo Biochem
  • Exact Sciences
  • Fujirebio
  • Grifols
  • Hologic
  • Illumina
  • LabCorp
  • Leica Biosystems
  • Li-Cor Biosciences
  • Myriad Genetics ortho-Clinical Diagnostics
  • PerkinElmer
  • Proteome Sciences
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • Shimadzu
  • Siemens Healthineers
  • Sierra Molecular
  • Takara Bio
  • Tecan Group
  • Thermo Fisher
  • Comprehensive listings of companies developing and marketing infectious disease molecular Diagnostic products, by test and application.
Opportunities and Strategic Recommendations
  • Specific new product development opportunities with potentially significant market appeal during the next five years.
  • Design criteria for new products.
  • Alternative market penetration strategies.
  • Potential market entry barriers and risks.
  • Business planning issues and concerns.
Contains 1,265 pages and 191 tables
Note: Product cover images may vary from those shown
2 of 2
  • Abbott
  • Affymetrix
  • Agilent Technologies
  • Applied Gene Technologies
  • Arca Biopharma
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biokit
  • bioMerieux
  • Bio-Rad
  • Biotest
  • Cepheid
  • Decode Genetics
  • Diadexus
  • Eiken Chemical
  • Elitech Group
  • Enzo Biochem
  • Exact Sciences
  • Fujirebio
  • Grifols
  • Hologic
  • Illumina
  • LabCorp
  • Leica Biosystems
  • Li-Cor Biosciences
  • Myriad Genetics
  • Ortho-Clinical Diagnostics
  • PerkinElmer
  • Proteome Sciences
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • Shimadzu
  • Siemens Healthineers
  • Sierra Molecular
  • Takara Bio
  • Tecan Group
  • Thermo Fisher
Note: Product cover images may vary from those shown
Adroll
adroll